Pharmascience

Founded in 1983, Pharmascience Inc. is the largest pharmaceutical employer in Quebec with 1,500 employees proudly headquartered in Montreal. Pharmascience Inc. is a full-service privately owned pharmaceutical company with strong roots in Canada and a growing global reach with product distribution in over 50 countries. Ranked 56th among Canada’s top 100 Research & Development (R&D) investors with over $39 million invested in 2019, Pharmascience Inc. is among the largest drug manufacturers in Canada. 

Pharmascience Inc. has strong values based on the importance of investing in its employees and young people. Through various programs and initiatives, the company ensures it supports their personal development and life. In 2020, Pharmascience Inc. has proudly been recognized for its investments by being selected as one of Canada’s Top Employers for Young People and named as one of Montreal’s best employers, as part of the Canada’s Top 100 Employers project. In 2021, the prestigious Forbes magazine ranked Pharmascience Inc. among its list of top 300 employers.

Pharmascience Inc. has strong long-standing philanthropic ties with its communities, both locally and internationally. For more than 20 years, Pharmascience has been working through Health Partners International of Canada (HPIC) as a partner of choice to increase access to medicine. Pharmascience’s total donations of essential medicine is close to $70 million.

Pharmascience Inc. is a leading manufacturer and marketer of prescription generic, over-the-counter, and behind-the-counter products as well as FDA approved Canadian-made injectables. The company commercializes nearly 300 product families in 20 different dosage forms for over 2,000 products. In Canada alone, more than 45 million prescriptions a year are filled with Pharmascience products. For more information, please visit www.pharmascience.com.

PHARMASCIENCE QUICK FACTS

Co-founded by pharmacists Morris Goodman and Ted Wise in 1983;

Largest pharmaceutical employer in Quebec with 1,500 employees;

Fourth largest generic pharmaceutical company in Canada;

Ranked 51st among Canada’s top 100 R&D investors with CAD $43 million invested annually;

Diversified portfolio of over 300 product families, both prescription and OTC;

Sales in more than 60 countries;

One of the largest providers of generic single-source products;

A leader in customer service & support.